EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Booster with intranasal vaccine candidate Mambisa activates the expression of tissue resident memory T cell markers

Daniel Palenzuela Gardón, Diogenes Quintana Vazquez, Hamlet Camacho Rodriguez, Dania Vazque Blomquist, Jorge Aguiar Santiago, Heryslina Izquierdo Reinoso, Chabeli Rodriguez Ibarra, Maité Delgado Espina, Anabel Alvarez Acosta, Alberto Cintado Benitez, Karen Cobas Acosta, Iris Valdez Prado und 10 weitere

Journal of Infectious Diseases · 26.06.2025 · 11 (1)

DOI: 10.52338/joid.2025.4900 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Infectious Diseases, online erschienen am 26.06.2025. Verfasst von Daniel Palenzuela Gardón und 21 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The study evaluates the efficacy of the nasal booster vaccine candidate Mambisa in the activation of tissue-resident memory T cells (TRM), that are essential in mucosal immunity against respiratory infections such as COVID-19. Mambisa, developed by the Center for Genetic Engineering and Biotechnology (CIGB) in Cuba, combines the RBD protein of SARS-CoV-2 and the HBcAg protein of hepatitis B, and is administered nasally. The preclinical study in mice showed that the nasal administration of Mambisa significantly increased the expression of CD69, and CD103 (TRM markers) in the lungs, while increased FOXP3 expression was also observed. Foxp3 is essential for the development and function of Treg cells, and can influence the activation and regulation of TRM cells. These results suggest that the combination of RBD and HBcAg induces an effective local immune response, with a synergistic effect that enhances TRM cell activation in tissues. Furthermore, mice immunized with Mambisa showed higher RBD-specific IgG antibody titers and increased neutralizing activity against the virus, compared to formulations with only RBD or HBcAg. In a study with nasal samples from 48 COVID-19 convalescent individuals receiving a booster shot with either Mambisa or intramuscular vaccine Abdala significant increases in the expression of genes associated with TRM (CD69, CD103) and effector immune responses (INFG, GZMB, CXCL10) were detected in the Mambisa group, indicating a local activation in the intranasal mucosa. In contrast, there were no significant differences in these markers in the Abdala group. TRM cells, residing in tissues such as the respiratory tract, act as a first line of defense, blocking viral replication and reducing transmission. The Mambisa formulation, by activating these markers, could enhance mucosal immunity, which is crucial in preventing emerging infections and variants. Moreover, the use of HBcAg as an adjuvant improves the RBD antigen presentation, enhan

Zitieren

APA

Gardón, D. P., Vazquez, D. Q., Rodriguez, H. C., Blomquist, D. V., Santiago, J. A., Reinoso, H. I., Ibarra, C. R., Espina, M. D., Acosta, A. A., Benitez, A. C., Acosta, K. C., Prado, I. V., Pérez, G. L., Tamayo, I. M. G., Alonso, I. R., Aguilar, J. C., Gonzalez, D. M., Fernandez, A. V., Izquierdo, R. A., …, & Nieto, G. G. (2025). Booster with intranasal vaccine candidate Mambisa activates the expression of tissue resident memory T cell markers. Journal of Infectious Diseases, 11(1). https://doi.org/10.52338/joid.2025.4900

Vancouver

Gardón DP, Vazquez DQ, Rodriguez HC, Blomquist DV, Santiago JA, Reinoso HI, et al. Booster with intranasal vaccine candidate Mambisa activates the expression of tissue resident memory T cell markers. Journal of Infectious Diseases. 2025;11(1). doi:10.52338/joid.2025.4900

BibTeX
@article{Gardn2025,
  author = {Gardón, Daniel Palenzuela and Vazquez, Diogenes Quintana and Rodriguez, Hamlet Camacho and Blomquist, Dania Vazque and Santiago, Jorge Aguiar and Reinoso, Heryslina Izquierdo and Ibarra, Chabeli Rodriguez and Espina, Maité Delgado and Acosta, Anabel Alvarez and Benitez, Alberto Cintado and Acosta, Karen Cobas and Prado, Iris Valdez and Pérez, Gilda Lemos and Tamayo, Isela María García and Alonso, Ingrid Rodriguez and Aguilar, Julio Cesar and Gonzalez, Damian Mainet and Fernandez, Amanda Visal and Izquierdo, Rubén Amaya and Noa, Diosladia Urquiza and Pérez, Pedro Puente and Nieto, Gerardo Guillen},
  title = {Booster with intranasal vaccine candidate Mambisa activates the expression of tissue resident memory T cell markers},
  journal = {Journal of Infectious Diseases},
  year = {2025},
  volume = {11},
  number = {1},
  doi = {10.52338/joid.2025.4900}
}
Kostenlos starten →